Indeed, it has been widely reported that the Akt/mTOR pathway plays a master role in pulmonary fibrosis, and several Akt/mTOR inhibitors in development or in clinical trials have been reported to minimize clinical pulmonary fibrosis46,47. The gene discussed is AKT1; the disease is pulmonary fibrosis.